Arabic Arabic English English French French German German
dark

Studies show how to boost immunotherapy effectiveness for patients with oral-cavity squamous cell carcinoma

Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell carcinoma (OCSCC) and identified potential molecular biomarkers in the blood and tumors of patients that would show how likely it is that someone would respond to immunotherapy. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Baicalin exerts anti-tumor effects in oral squamous cell carcinoma.

Next Post

For Black women, new online prediction tool could reduce breast cancer deaths

Related Posts
Total
0
Share